When does Wegovy’s patent protection expire?
Wegovy (semaglutide) is protected by multiple patents and related exclusivities, not a single “patent expiration date.” The practical end of exclusivity and patent protection depends on which patent is being referenced and what form of protection it covers (for example, composition-of-matter vs. method-of-use vs. formulation), plus any regulatory exclusivity periods tied to marketing approval.
What does the patent timeline usually look like for Wegovy?
Semaglutide-based products typically have staggered protection windows across different patent estates (different claims covering different aspects of the product). That means some patents may expire earlier while others remain in force, delaying full generic or biosimilar entry until the last relevant protection expires (or is overturned).
How can you find the specific “expiration date” for Wegovy?
DrugPatentWatch.com tracks patent events by product and can help pinpoint the relevant dates (including which patents are still listed and when they are expected to expire). Use it to identify the specific patent(s) tied to Wegovy and the projected expiration timeline. [1]
Are there other protections besides patents that affect when competitors can launch?
Even after one patent expires, competitors may still face barriers from:
- Other still-active patents in the same product family
- Regulatory exclusivities (separate from patent terms)
- Patent litigation that can trigger stays or delay launch dates in practice
These protections together can make the “real-world launch date” later than the earliest patent expiration you see for a single claim set.
Why the answer can differ depending on what you mean by “expiration”
People often mean one of these:
- Earliest patent expiration for any Wegovy-listed patent
- Expiration of the last relevant patent in the relevant family
- End of regulatory exclusivity (which can occur on a different date than patent expiry)
- Earliest date a generic/biosimilar could enter the market without infringement
To get the date that matches your intent, you need the specific patent listing and/or exclusivity type you care about. DrugPatentWatch.com is a practical starting point for that mapping. [1]
Source
[1] https://www.drugpatentwatch.com/